STEVENSON, Wash., April 26, 2011 (GLOBE NEWSWIRE) -- Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUSE), announced today that Marvin S. Hausman, M.D. has been selected to present a paper at the Navy and Marine Corps Combat & Operational Stress Control Conference 2011, San Diego California; April 26-29. The presentation is entitled: "Anti-inflammatory Approach to Control and Suppression of Post-Traumatic Stress Disorder (PTSD), Combat Operational Stress (COS), Traumatic Brain Injury (TBI), and Depression."
D-Traum™ is an innovative mushroom-based, whole food natural supplement developed using proprietary TNS food technology. TNS has patent pending-technology that can naturally enhance the delivery of certain potent bionutrients and antioxidants within mushrooms. D-Traum™ contains the Agaricus blazei Murill mushroom which has been exposed to pulsed UV-light to enhance the natural levels of vitamin D. Biologic clinical models (Drosophila fruit flies and horses) were used to confirm bionutrient activity and efficacy.
About the Naval Center for Combat & Operational Stress Control Center
The Naval Center for Combat & Operational Stress Control (NCCOSC) is dedicated to the mental health and well-being of Navy and Marine Corps service members and their families.
The major focus of the Center is to promote resilience and to investigate and implement the best practices in the diagnoses and treatment of post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). The center is a program of the U.S. Navy Bureau of Medicine & Surgery (BUMED).
About Total Nutraceutical Solutions, Inc.
Total Nutraceutical Solutions, Inc. (TNS) is an emerging biotechnology company engaged in the discovery, formulation, and marketing of organic ingredients that are used in cosmetic and nutraceutical products developed and sold by TNS and by third parties. These ingredients, which currently include L-Ergothioneine, beta-glucans, polyphenols, and vitamin D, address a wide variety of health conditions affecting humans and animals. Our scientific strategy and technology platform currently focuses on the manufacturing and health benefits of specific bioactive nutrients found exclusively in certain whole natural mushrooms and their mycelial biomasses. We utilize innovative clinical models, biomarkers, and analytical tools to show the nutritional and clinical efficacy of our ingredients and the products that incorporate them.
The Total Nutraceutical Solutions, Inc. logo is available at
Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Total Nutraceutical Solutions (TNS), Inc., with the Securities and Exchange Commission. Further information on risks faced by TNS are detailed in the Form 10-K for the year ended December 31, 2009, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at . The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. TNS does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
CONTACT: Roberta Matta 509-427-5132 TotalNutraceutical.com
